Mechanisms underlying the weight loss effects of RYGB and SG: similar, yet different

Journal of Endocrinological Investigation

Volumn 42, Issue 2, 2019, Pages 117-128

  Pucci, A ^a,b   Batterham, R L ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Bile acids; Gut hormones; Gut microbiota; Roux en Y gastric bypass; Sleeve gastrectomy; Type 2 diabetes

Indexed keywords

BILE ACID; CHOLECYSTOKININ; GASTRIC INHIBITORY POLYPEPTIDE; GASTRIN; GASTROINTESTINAL HORMONE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; NEUROTENSIN; OXYNTOMODULIN; PEPTIDE YY [3-36];

BODY MASS; BODY WEIGHT LOSS; CALORIC RESTRICTION; DYSBIOSIS; GLUCOSE TRANSPORT; HORMONE ACTION; HUMAN; INTESTINE FLORA; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; ODOR; PATHOPHYSIOLOGY; REVIEW; ROUX-EN-Y GASTRIC BYPASS; SLEEVE GASTRECTOMY; SURGICAL TECHNIQUE; TASTE; THERAPY EFFECT; TREATMENT OUTCOME; VAGUS NERVE; GASTRECTOMY; GASTRIC BYPASS SURGERY; MORBID OBESITY; PHYSIOLOGY; PROCEDURES;

GASTRECTOMY; GASTRIC BYPASS; HUMANS; OBESITY, MORBID; WEIGHT LOSS;

EID: 85046408353     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/s40618-018-0892-2     Document Type: Review

References (96)

1. WHO Global health observatory (GHO) data 2016 Available from: http://www.who.int/gho/ncd/risk_factors/overweight_obesity/obesity_adults/en/
2. Gloy VL, Briel M, Bhatt DL et al (2013) Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ 347:f5934. 10.1136/bmj.f5934 (clinical research ed)
3. Makaronidis JM, Batterham RL (2016) Potential mechanisms mediating sustained weight loss following Roux-en-Y gastric bypass and sleeve gastrectomy. Endocrinol Metab Clin North Am 45(3):539–552. 10.1016/j.ecl.2016.04.006
4. Schauer PR, Bhatt DL, Kirwan JP et al (2017) Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes. N Engl J Med 376(7):641–651. 10.1056/NEJMoa1600869
5. Sjostrom L (2013) Review of the key results from the Swedish Obese Subjects (SOS) trial—a prospective controlled intervention study of bariatric surgery. J Intern Med 273(3):219–234. 10.1111/joim.12012
6. Radaelli MG, Martucci F, Perra S et al (2017) NAFLD/NASH in patients with type 2 diabetes and related treatment options. J Endocrinol Invest. 10.1007/s40618-017-0799-3
7. Saber AA, Elgamal MH, McLeod MK (2008) Bariatric surgery: the past, present, and future. Obes Surg 18(1):121–128. 10.1007/s11695-007-9308-7
8. Payne JH, Dewind LT, Commons RR (1963) Metabolic observations in patients with jejunocolic shunts. Am J Surg 106:273–289
9. Sherman CD Jr, May AG, Nye W et al (1965) Clinical and metabolic studies following bowel by-passing for obesity. Ann N Y Acad Sci 131(1):614–622
10. Buchwald H (2014) The evolution of metabolic/bariatric surgery. Obes Surg 24(8):1126–1135. 10.1007/s11695-014-1354-3
11. Mason EE, Ito C (1967) Gastric bypass in obesity. Surg Clin N Am 47(6):1345–1351
12. Angrisani L, Santonicola A, Iovino P et al (2017) Bariatric surgery and endoluminal procedures: IFSO worldwide survey 2014. Obes Surg 27(9):2279–2289. 10.1007/s11695-017-2666-x
13. Manning S, Pucci A, Carter NC et al (2015) Early postoperative weight loss predicts maximal weight loss after sleeve gastrectomy and Roux-en-Y gastric bypass. Surg Endosc 29(6):1484–1491. 10.1007/s00464-014-3829-7
14. Pucci A, Tymoszuk U, Cheung WH et al (2018) Type 2 diabetes remission 2 years post Roux-en-Y gastric bypass and sleeve gastrectomy: the role of the weight loss and comparison of DiaRem and DiaBetter scores. Diabet Med J Br Diabet Assoc 35(3):360–367. 10.1111/dme.13532
15. Olbers T, Lonroth H, Fagevik-Olsen M et al (2003) Laparoscopic gastric bypass: development of technique, respiratory function, and long-term outcome. Obes Surg 13(3):364–370. 10.1381/096089203765887679
16. Abu-Jaish W, Rosenthal RJ (2010) Sleeve gastrectomy: a new surgical approach for morbid obesity. Expert Rev Gastroenterol Hepatol 4(1):101–119. 10.1586/egh.09.68
17. Halperin F, Ding SA, Simonson DC et al (2014) Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial. JAMA Surg 149(7):716–726. 10.1001/jamasurg.2014.514
18. Courcoulas AP, Belle SH, Neiberg RH et al (2015) Three-year outcomes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment: a randomized clinical trial. JAMA Surg 150(10):931–940. 10.1001/jamasurg.2015.1534
19. Schauer PR, Bhatt DL, Kirwan JP et al (2014) Bariatric surgery versus intensive medical therapy for diabetes–3-year outcomes. N Engl J Med 370(21):2002–2013. 10.1056/NEJMoa1401329
20. Peterli R, Wolnerhanssen BK, Peters T et al (2018) Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial. JAMA 319(3):255–265. 10.1001/jama.2017.20897
21. Salminen P, Helmio M, Ovaska J et al (2018) Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y Gastric bypass on weight loss at 5 years among patients with morbid obesity: the SLEEVEPASS randomized clinical trial. JAMA 319(3):241–254. 10.1001/jama.2017.20313
22. Ignat M, Vix M, Imad I et al (2017) Randomized trial of Roux-en-Y gastric bypass versus sleeve gastrectomy in achieving excess weight loss. Br J Surg 104(3):248–256. 10.1002/bjs.10400
23. Osland E, Yunus RM, Khan S et al (2017) Weight loss outcomes in laparoscopic vertical sleeve gastrectomy (LVSG) versus laparoscopic Roux-en-Y gastric bypass (LRYGB) procedures: a meta-analysis and systematic review of randomized controlled trials. Surg Laparosc Endosc Percutaneous Tech 27(1):8–18. 10.1097/sle.0000000000000374
24. Kashyap SR, Bhatt DL, Wolski K et al (2013) Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment. Diabetes Care 36(8):2175–2182. 10.2337/dc12-1596
25. Miras AD, le Roux CW (2013) Mechanisms underlying weight loss after bariatric surgery. Nat Rev Gastroenterol Hepatol 10(10):575–584. 10.1038/nrgastro.2013.119
26. Makaronidis JM, Batterham RL (2018) Obesity, body weight regulation and the brain: insights from fMRI. Br J Radiol. 10.1259/bjr.20170910
27. Scott WR, Batterham RL (2011) Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: understanding weight loss and improvements in type 2 diabetes after bariatric surgery. Am J Physiol Regul Integr Comp Physiol 301(1):R15–R27. 10.1152/ajpregu.00038.2011
28. Batterham RL, Cowley MA, Small CJ et al (2002) Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418(6898):650–654. 10.1038/nature02666
29. Manning S, Pucci A, Batterham RL (2015) GLP-1: a mediator of the beneficial metabolic effects of bariatric surgery? Physiology (Bethesda, Md) 30(1):50–62. 10.1152/physiol.00027.2014
30. Batterham RL, Ffytche DH, Rosenthal JM et al (2007) PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans. Nature 450(7166):106–109. 10.1038/nature06212
31. Guida C, Stephen S, Guitton R et al (2017) The role of PYY in pancreatic islet physiology and surgical control of diabetes. Trends Endocrinol Metab TEM 28(8):626–636. 10.1016/j.tem.2017.04.005
32. Pucci A, Finer N (2015) New medications for treatment of obesity: metabolic and cardiovascular effects. Can J Cardiol 31(2):142–152. 10.1016/j.cjca.2014.11.010
33. Muller TD, Nogueiras R, Andermann ML et al (2015) Ghrelin. Mol Metab 4(6):437–460. 10.1016/j.molmet.2015.03.005
34. Berthoud HR (2011) Metabolic and hedonic drives in the neural control of appetite: who is the boss? Curr Opin Neurobiol 21(6):888–896. 10.1016/j.conb.2011.09.004
35. Seeley RJ, Chambers AP, Sandoval DA (2015) The role of gut adaptation in the potent effects of multiple bariatric surgeries on obesity and diabetes. Cell Metab 21(3):369–378. 10.1016/j.cmet.2015.01.001
36. Thomas C, Gioiello A, Noriega L et al (2009) TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab 10(3):167–177. 10.1016/j.cmet.2009.08.001
37. Dufer M, Horth K, Wagner R et al (2012) Bile acids acutely stimulate insulin secretion of mouse beta-cells via farnesoid X receptor activation and K(ATP) channel inhibition. Diabetes 61(6):1479–1489. 10.2337/db11-0815
38. Lundasen T, Galman C, Angelin B et al (2006) Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man. J Intern Med 260(6):530–536. 10.1111/j.1365-2796.2006.01731.x
39. Fang S, Suh JM, Reilly SM et al (2015) Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance. Nat Med 21(2):159–165. 10.1038/nm.3760
40. Watanabe M, Houten SM, Mataki C et al (2006) Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439(7075):484–489. 10.1038/nature04330
41. Suzuki T, Aoyama J, Hashimoto M et al (2014) Correlation between postprandial bile acids and body fat mass in healthy normal-weight subjects. Clin Biochem 47(12):1128–1131. 10.1016/j.clinbiochem.2014.04.025
42. Turnbaugh PJ, Ley RE, Hamady M et al (2007) The human microbiome project. Nature 449(7164):804–810. 10.1038/nature06244
43. Martinez KB, Pierre JF, Chang EB (2016) The gut microbiota: the gateway to improved metabolism. Gastroenterol Clin N Am 45(4):601–614. 10.1016/j.gtc.2016.07.001
44. Cummings DE (2015) Taste and the regulation of food intake: it’s not just about flavor. Am J Clin Nutr 102(4):717–718. 10.3945/ajcn.115.120667
45. Piaggi P, Vinales KL, Basolo A et al (2018) Energy expenditure in the etiology of human obesity: spendthrift and thrifty metabolic phenotypes and energy-sensing mechanisms. J Endocrinol Invest 41(1):83–89. 10.1007/s40618-017-0732-9
46. Glicksman C, Pournaras DJ, Wright M et al (2010) Postprandial plasma bile acid responses in normal weight and obese subjects. Ann Clin Biochem 47(Pt 5):482–484. 10.1258/acb.2010.010040
47. Aron-Wisnewsky J, Clement K (2014) The effects of gastrointestinal surgery on gut microbiota: potential contribution to improved insulin sensitivity. Curr Atheroscler Rep 16(11):454. 10.1007/s11883-014-0454-9
48. Turnbaugh PJ, Hamady M, Yatsunenko T et al (2009) A core gut microbiome in obese and lean twins. Nature 457(7228):480–484. 10.1038/nature07540
49. Turnbaugh PJ, Ridaura VK, Faith JJ et al (2009) The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 1(6):6ra14. 10.1126/scitranslmed.3000322
50. Backhed F, Ding H, Wang T et al (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 101(44):15718–15723. 10.1073/pnas.0407076101
51. Tambo A, Roshan MH, Pace NP (2016) The microbial hypothesis: contributions of adenovirus infection and metabolic endotoxaemia to the pathogenesis of obesity. Int J Chronic Dis 2016:7030795. 10.1155/2016/7030795
52. Turnbaugh PJ, Ley RE, Mahowald MA et al (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444(7122):1027–1031. 10.1038/nature05414
53. Barkeling B, King NA, Naslund E et al (2007) Characterization of obese individuals who claim to detect no relationship between their eating pattern and sensations of hunger or fullness. Int J Obes (2005) 31(3):435–439. 10.1038/sj.ijo.0803449
54. Sumithran P, Prendergast LA, Delbridge E et al (2011) Long-term persistence of hormonal adaptations to weight loss. N Engl J Med 365(17):1597–1604. 10.1056/NEJMoa1105816
55. Leibel RL, Hirsch J (1984) Diminished energy requirements in reduced-obese patients. Metab Clin Exp 33(2):164–170
56. Browning KN, Fortna SR, Hajnal A (2013) Roux-en-Y gastric bypass reverses the effects of diet-induced obesity to inhibit the responsiveness of central vagal motoneurones. J Physiol 591(9):2357–2372. 10.1113/jphysiol.2012.249268
57. Mann T, Tomiyama AJ, Westling E et al (2007) Medicare’s search for effective obesity treatments: diets are not the answer. Am Psychol 62(3):220–233. 10.1037/0003-066x.62.3.220
58. Ionut V, Bergman RN (2011) Mechanisms responsible for excess weight loss after bariatric surgery. J Diabetes Sci Technol 5(5):1263–1282. 10.1177/193229681100500536
59. Odstrcil EA, Martinez JG, Santa Ana CA et al (2010) The contribution of malabsorption to the reduction in net energy absorption after long-limb Roux-en-Y gastric bypass. Am J Clin Nutr 92(4):704–713. 10.3945/ajcn.2010.29870
60. Manning S, Pucci A, Batterham RL (2015) Roux-en-Y gastric bypass: effects on feeding behavior and underlying mechanisms. J Clin Investig 125(3):939–948. 10.1172/jci76305
61. Dar MS, Chapman WH 3rd, Pender JR et al (2012) GLP-1 response to a mixed meal: what happens 10 years after Roux-en-Y gastric bypass (RYGB)? Obes Surg 22(7):1077–1083. 10.1007/s11695-012-0624-1
62. Yousseif A, Emmanuel J, Karra E et al (2014) Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and active GLP-1 levels in non-diabetic humans. Obes Surg 24(2):241–252. 10.1007/s11695-013-1066-0
63. Cummings DE, Weigle DS, Frayo RS et al (2002) Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 346(21):1623–1630. 10.1056/NEJMoa012908
64. Chandarana K, Drew ME, Emmanuel J et al (2009) Subject standardization, acclimatization, and sample processing affect gut hormone levels and appetite in humans. Gastroenterology 136(7):2115–2126. 10.1053/j.gastro.2009.02.047
65. Dirksen C, Jorgensen NB, Bojsen-Moller KN et al (2013) Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass. Int J Obes (2005) 37(11):1452–1459. 10.1038/ijo.2013.15
66. le Roux CW, Welbourn R, Werling M et al (2007) Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg 246(5):780–785. 10.1097/SLA.0b013e3180caa3e3
67. Svane MS, Jorgensen NB, Bojsen-Moller KN et al (2016) Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery. Int J Obes (2005) 40(11):1699–1706. 10.1038/ijo.2016.121
68. Pucci A, Cheung WH, Jones J et al (2015) A case of severe anorexia, excessive weight loss and high peptide YY levels after sleeve gastrectomy. Endocrinol Diabetes Metab Case Rep 2015:150020. 10.1530/edm-15-0020
69. Rao RS, Kini S (2011) GIP and bariatric surgery. Obes Surg 21(2):244–252. 10.1007/s11695-010-0305-x
70. Salinari S, Bertuzzi A, Asnaghi S et al (2009) First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery. Diabetes Care 32(3):375–380. 10.2337/dc08-1314
71. Rubino F, Gagner M, Gentileschi P et al (2004) The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg 240(2):236–242
72. Suzuki K, Jayasena CN, Bloom SR (2012) Obesity and appetite control. Exp Diabetes Res 2012:824305. 10.1155/2012/824305
73. Peterli R, Steinert RE, Woelnerhanssen B et al (2012) Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes Surg 22(5):740–748. 10.1007/s11695-012-0622-3
74. Jacobsen SH, Olesen SC, Dirksen C et al (2012) Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects. Obes Surg 22(7):1084–1096. 10.1007/s11695-012-0621-4
75. Sillakivi T, Suumann J, Kirsimagi U et al (2013) Plasma levels of gastric biomarkers in patients after bariatric surgery: biomarkers after bariatric surgery. Hepatogastroenterology 60(128):2129–2132
76. Egerod KL, Engelstoft MS, Grunddal KV et al (2012) A major lineage of enteroendocrine cells coexpress CCK, secretin, GIP, GLP-1, PYY, and neurotensin but not somatostatin. Endocrinology 153(12):5782–5795. 10.1210/en.2012-1595
77. Steinert RE, Peterli R, Keller S et al (2013) Bile acids and gut peptide secretion after bariatric surgery: a 1-year prospective randomized pilot trial. Obesity (Silver Spring, Md) 21(12):E660–E668. 10.1002/oby.20522
78. Pournaras DJ, Glicksman C, Vincent RP et al (2012) The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology 153(8):3613–3619. 10.1210/en.2011-2145
79. Ahmad NN, Pfalzer A (2005) Kaplan LM (2013) Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity. Int J Obes 37(12):1553–1559. 10.1038/ijo.2013.38
80. Liou AP, Paziuk M, Luevano JM Jr et al (2013) Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med 5(178):178141. 10.1126/scitranslmed.3005687
81. Ryan KK, Tremaroli V, Clemmensen C et al (2014) FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature 509(7499):183–188. 10.1038/nature13135
82. Midtvedt T, Norman A, Nygaard K (1969) Bile acid transforming micro-organisms in rats with an intestinal blind segment. Acta Pathologica et microbiologica Scandinavica 77(1):162–166
83. Liu H, Hu C, Zhang X et al (2018) Role of gut microbiota, bile acids and their cross-talk in the effects of bariatric surgery on obesity and type 2 diabetes. J Diabetes Investig 9(1):13–20. 10.1111/jdi.12687
84. Tremaroli V, Karlsson F, Werling M et al (2015) Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation. Cell Metab 22(2):228–238. 10.1016/j.cmet.2015.07.009
85. Furet JP, Kong LC, Tap J et al (2010) Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes 59(12):3049–3057. 10.2337/db10-0253
86. Dethlefsen L, Relman DA (2011) Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci USA 108(Suppl 1):4554–4561. 10.1073/pnas.1000087107
87. Murphy R, Tsai P, Jullig M et al (2017) Differential changes in gut microbiota after gastric bypass and sleeve gastrectomy bariatric surgery vary according to diabetes remission. Obes Surg 27(4):917–925. 10.1007/s11695-016-2399-2
88. Medina DA, Pedreros JP, Turiel D et al (2017) Distinct patterns in the gut microbiota after surgical or medical therapy in obese patients. PeerJ 5:e3443. 10.7717/peerj.3443
89. Guo Y, Liu CQ, Shan CX et al (2017) Gut microbiota after Roux-en-Y gastric bypass and sleeve gastrectomy in a diabetic rat model: increased diversity and associations of discriminant genera with metabolic changes. Diabetes/Metab Res Rev. 10.1002/dmrr.2857
90. Cavin JB, Couvelard A, Lebtahi R et al (2016) Differences in alimentary glucose absorption and intestinal disposal of blood glucose after Roux-en-Y gastric bypass vs sleeve gastrectomy. Gastroenterology 150(2):454–464. 10.1053/j.gastro.2015.10.009
91. Saeidi N, Meoli L, Nestoridi E et al (2013) Reprogramming of intestinal glucose metabolism and glycemic control in rats after gastric bypass. Science (New York, NY) 341(6144):406–410. 10.1126/science.1235103
92. Baud G, Daoudi M, Hubert T et al (2016) Bile diversion in Roux-en-Y gastric bypass modulates sodium-dependent glucose intestinal uptake. Cell Metab 23(3):547–553. 10.1016/j.cmet.2016.01.018
93. Zakeri R, Batterham RL (2018) Potential mechanisms underlying the effect of bariatric surgery on eating behaviour. Curr Opin Endocrinol Diabetes Obes 25(1):3–11. 10.1097/med.0000000000000379
94. Berthoud HR (2008) Vagal and hormonal gut-brain communication: from satiation to satisfaction. Neurogastroenterol Motil 20(Suppl 1):64–72. 10.1111/j.1365-2982.2008.01104.x
95. Berthoud HR, Shin AC, Zheng H (2011) Obesity surgery and gut-brain communication. Physiol Behav 105(1):106–119. 10.1016/j.physbeh.2011.01.023
96. Leibel RL, Seeley RJ, Darsow T et al (2015) Biologic responses to weight loss and weight regain: report from an American diabetes association research symposium. Diabetes 64(7):2299–2309. 10.2337/db15-0004